肽核酸，類肽和多肽定制合成服務(wù)以及肽核酸單體，類肽單體
普通會(huì)員
產(chǎn)品價(jià)格面議
產(chǎn)品品牌賽曼諾生物
最小起訂≥5 mg
供貨總量1000 mg
發(fā)貨期限自買家付款之日起 3 天內(nèi)發(fā)貨
瀏覽次數(shù)44
企業(yè)旺鋪http://cellmano.sjooo.com/
更新日期2015-02-06 13:44
會(huì)員級(jí)別：企業(yè)會(huì)員
已 繳 納：0.00 元保證金
我的勛章： [誠(chéng)信檔案]
在線客服：
企業(yè)二維碼： 企業(yè)名稱加二維碼
品牌： |
賽曼諾生物 |
所在地： |
安徽 合肥市 |
起訂： |
≥5 mg |
供貨總量： |
1000 mg |
有效期至： |
長(zhǎng)期有效 |
| Pancreatic Polypeptide (rat) | C195H298N58O57S | 4398.93 | 90419-12-8 | H-Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 |
| Pancreatic Polypeptide (rana temporaria) | C192H276N52O58 | 4240.62 | 132187-74-7 | H-Ala-Pro-Ser-Glu-Pro-His-His-Pro-Gly-Asp-Gln-Ala-Thr-Gln-Asp-Gln-Leu-Ala-Gln-Tyr-Tyr-Ser-Asp-Leu-Tyr-Gln-Tyr-Ile-Thr-Phe-Val-Thr-Arg-Pro-Arg-Phe-NH2 |
| Pancreatic Polypeptide (31-36) (human) | C36H61N13O8 | 803.96 | 74012-13-8 | H-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 |
| Pancreatic Polypeptide (31-36) (free acid) (human) | C36H60N12O9 | 804.95 | 192432-73-8 | H-Leu-Thr-Arg-Pro-Arg-Tyr-OH |
| PAR-1 (1-6) (mouse, rat) Thrombin Receptor (1-6) (mouse, rat), Proteinase Activated Receptor 1 (1-6) (mouse, rat), SFFLRN |
C37H54N10O9 | 782.90 | 140436-67-5 | H-Ser-Phe-Phe-Leu-Arg-Asn-OH |
| (Phe1,Ser2,Tyr6)-PAR-1 (1-6) amide (human) FSLLRYamide, (Phe1,Ser2,Tyr6)-Coagulation Factor II Receptor (1-6) amide (mouse), (Phe1,Ser2,Tyr6)-Proteinase Activated Receptor 1 (1-6) amide (human), (Phe1,Ser2,Tyr6)-Thrombin Receptor (1-6) amide (human) |
C39H60N10O8 | 796.97 | 245329-02-6 | H-Phe-Ser-Leu-Leu-Arg-Tyr-NH2 |
| PAR-2 (1-6) (human) Thrombin Receptor-Like 1 (1-6) (human), SLIGKV, Proteinase Activated Receptor 2 (1-6) (human), Coagulation Factor II Receptor-Like 1 (1-6) (human) |
C28H53N7O8 | 615.77 | 202933-49-1 | H-Ser-Leu-Ile-Gly-Lys-Val-OH |
| PAR-2 (1-6) (mouse, rat) Coagulation Factor II Receptor-Like 1 (1-6) (mouse, rat), Proteinase Activated Receptor 2 (1-6) (mouse, rat), SLIGRL, Thrombin Receptor-Like 1 (1-6) (mouse, rat) |
C29H55N9O8 | 657.81 | 164081-25-8 | H-Ser-Leu-Ile-Gly-Arg-Leu-OH |
| PAR-2 (1-6) amide (human) Thrombin Receptor-Like 1 (1-6) amide (human), SLIGKVamide, Proteinase Activated Receptor 2 (1-6) amide (human), Coagulation Factor II Receptor-Like 1 (1-6) amide (human) |
C28H54N8O7 | 614.79 | 190383-13-2 | H-Ser-Leu-Ile-Gly-Lys-Val-NH2 |
| PAR-2 (6-1) amide (human) retro-PAR-2 (1-6) amide (human), retro-SLIGKVamide, Thrombin Receptor-Like 1 (6-1) amide (human), Proteinase Activated Receptor 2 (6-1) amide (human), VKGILSamide, Coagulation Factor II Receptor-Like 1 (6-1) amide (human) |
C28H54N8O7 | 614.79 | 942413-05-0 | H-Val-Lys-Gly-Ile-Leu-Ser-NH2 |
| PAR-2 (1-6) amide (mouse, rat) Thrombin Receptor-Like 1 (1-6) amide (mouse, rat), SLIGRLamide, Proteinase Activated Receptor 2 (1-6) amide (mouse, rat), Coagulation Factor II Receptor-Like 1 (1-6) amide (mouse, rat) |
C29H56N10O7 | 656.83 | 171436-38-7 | H-Ser-Leu-Ile-Gly-Arg-Leu-NH2 |
| 2-(2-Furoyl)-PAR-2 (2-6)-Orn amide (mouse, rat) 2-(2-Furoyl)-LIGRLOamide |
C36H63N11O8 | 777.97 | 729589-58-6 | 2-(2-Furoyl)-Leu-Ile-Gly-Arg-Leu-Orn-NH2 |
| PAR-2 (6-1) amide (mouse, rat) LRGILSamide |
C29H56N10O7 | 656.83 | 245329-01-5 | H-Leu-Arg-Gly-Ile-Leu-Ser-NH2 |
| PAR-3 (1-6) (human) Coagulation Factor II Receptor-Like 2 (1-6) (human), Proteinase Activated Receptor 3 (1-6) (human), Thrombin Receptor-Like 2 (1-6) (human), TFRGAP |
C29H45N9O8 | 647.73 | 320347-28-2 | H-Thr-Phe-Arg-Gly-Ala-Pro-OH |
| PAR-3 (1-6) amide (human) Coagulation Factor II Receptor-Like 2 (1-6) amide (human), Thrombin Receptor-Like 2 (1-6) amide (human), Proteinase Activated Receptor 3 (1-6) amide (human), TFRGAPamide |
C29H46N10O7 | 646.75 | H-Thr-Phe-Arg-Gly-Ala-Pro-NH2 | |
| PAR-3 (1-6) amide (mouse) Proteinase Activated Receptor 3 (1-6) amide (mouse), SFNGGPamide, Thrombin Receptor-Like 2 (1-6) amide (mouse), Coagulation Factor II Receptor-Like 2 (1-6) amide (mouse) |
C25H36N8O8 | 576.61 | 261521-21-5 | H-Ser-Phe-Asn-Gly-Gly-Pro-NH2 |
| PAR-4 (1-6) (human) GYPGQV, Coagulation Factor II Receptor-Like 3 (1-6) (human), Proteinase Activated Receptor 4 (1-6) (human), Thrombin Receptor-Like 3 (1-6) (human) |
C28H41N7O9 | 619.68 | 225779-44-2 | H-Gly-Tyr-Pro-Gly-Gln-Val-OH |
| PAR-4 (1-6) (mouse) Thrombin Receptor-Like 3 (1-6) (mouse), Proteinase Activated Receptor 4 (1-6) (mouse), Coagulation Factor II Receptor-Like 3 (1-6) (mouse), GYPGKF |
C33H45N7O8 | 667.76 | 213018-42-9 | H-Gly-Tyr-Pro-Gly-Lys-Phe-OH |
| (Ala1)-PAR-4 (1-6) (mouse) (Ala1)-Thrombin Receptor-Like 3 (1-6) (mouse), (Ala1)-Proteinase Activated Receptor 4 (1-6) (mouse), (Ala1)-Coagulation Factor II Receptor-Like 3 (1-6) (mouse), AYPGKF |
C34H47N7O8 | 681.79 | 380900-00-5 | H-Ala-Tyr-Pro-Gly-Lys-Phe-OH |
| PAR-4 (1-6) amide (human) Thrombin Receptor-Like 3 (1-6) amide (human), Proteinase Activated Receptor 4 (1-6) amide (human), GYPGQVamide, Coagulation Factor II Receptor-Like 3 (1-6) amide (human) |
C28H42N8O8 | 618.69 | 245443-51-0 | H-Gly-Tyr-Pro-Gly-Gln-Val-NH2 |
| PAR-4 (1-6) amide (mouse) Coagulation Factor II Receptor-Like 3 (1-6) amide (mouse), GYPGKFamide, Proteinase Activated Receptor 4 (1-6) amide (mouse), Thrombin Receptor-Like 3 (1-6) amide (mouse) |
C33H46N8O7 | 666.78 | 245443-52-1 | H-Gly-Tyr-Pro-Gly-Lys-Phe-NH2 |
| (Ala1)-PAR-4 (1-6) amide (mouse) AYPGKFamide, (Ala1)-Thrombin Receptor-Like 3 (1-6) amide (mouse), (Ala1)-Coagulation Factor II Receptor-Like 3 (1-6) amide (mouse), (Ala1)-Proteinase Activated Receptor 4 (1-6) amide (mouse) |
C34H48N8O7 | 680.80 | 352017-71-1 | H-Ala-Tyr-Pro-Gly-Lys-Phe-NH2 |
| C25H38N6O6 | 518.61 | 74875-72-2 | Boc-D-Phe-Pro-Arg-OH | |
| Acetyl-Pepstatin | C31H57N5O9 | 643.82 | 28575-34-0 | Ac-Val-Val-Sta-Ala-Sta-OH |
| C39H65N5O9 | 747.97 | 98092-14-9 | Isovaleryl-Phe-Nle-Sta-Ala-Sta-OH | |
| C25H47N3O6 | 485.66 | 120849-36-7 | Isovaleryl-Val-Val-Sta-Oet | |
| Pepstatin A | C34H63N5O9 | 685.90 | 26305-03-3 | Isovaleryl-Val-Val-Sta-Ala-Sta-OH |
| (D-Ala1)-Peptide T | C35H55N9O16 | 857.87 | 106362-33-8 | H-D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-OH |
| (D-Ala1)-Peptide T amide DAPTA |
C35H56N10O15 | 856.89 | 106362-34-9 | H-D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2 |
| Peptide YY (human), PYY (human) | C194H295N55O57 | 4309.81 | 118997-30-1 | H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 |
| (Leu31,Pro34)-Peptide YY (human), (Leu31,Pro34)-PYY (human) | C195H296N54O56 | 4292.83 | 179986-95-9 | H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 |
| (Pro34)-Peptide YY (human), (Pro34)-PYY (human) | C194H294N54O56 | 4278.8 | 179986-93-7 | H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Pro-Arg-Tyr-NH2 |
| Peptide YY (canine, mouse, porcine, rat), PYY (canine, mouse, porcine, rat) | C190H288N54O57 | 4240.71 | 81858-94-8 | H-Tyr-Pro-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 |
| Peptide YY (3-36) (canine, mouse, porcine, rat), PYY (3-36) (canine, mouse, porcine, rat) | C176H272N52O54 | 3980.41 | 126339-09-1 | H-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 |
| Peptide YY (3-36) (human), PYY (3-36) (human) | C180H279N53O54 | 4049.52 | 123583-37-9 | H-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 |
| Peptide YY (13-36) (canine, mouse, porcine, rat), PYY (13-36) (canine, mouse, porcine, rat) | C135H209N41O38 | 3014.4 | 86895-09-2 | H-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 |
| Physalaemin | C58H84N14O16S | 1265.46 | 2507-24-6 | Pyr-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH2 |
| H-Lys-Phe-Tyr-OH | C24H32N4O5 | 456.54 | 63958-93-0 | H-Lys-Phe-Tyr-OH |
| H-Phe-Tyr-OH | C18H20N2O4 | 328.37 | 17355-18-9 | H-Phe-Tyr-OH |
| C34H53N9O13 | 795.85 | Pyr-Val-Asp-Pro-Asn-Ile-Gln-OH | ||
| C37H58N10O14 | 866.93 | Pyr-Val-Asp-Pro-Asn-Ile-Gln-Ala-OH | ||
| PACAP Related Peptide (1-29) (rat), PRP (1-29) (rat) | C148H242N42O45S | 3361.87 | 132769-35-8 | H-Asp-Val-Ala-His-Glu-Ile-Leu-Asn-Glu-Ala-Tyr-Arg-Lys-Val-Leu-Asp-Gln-Leu-Ser-Ala-Arg-Lys-Tyr-Leu-Gln-Ser-Met-Val-Ala-OH |
| PACAP-27 (human, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-27 (human, mouse, ovine, porcine, rat), PACAP-38 (1-27) amide (human, mouse, ovine, porcine, rat) | C142H224N40O39S | 3147.65 | 127317-03-7 | H-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2 |
| PACAP-27 (6-27) (human, chicken, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-27 (6-27) (human, chicken, mouse, ovine, porcine, rat) | C121H193N33O31S | 2638.13 | 136134-68-4 | H-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2 |
| PACAP-38 (human, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-38 (human, mouse, ovine, porcine, rat) | C203H331N63O53S | 4534.32 | 124123-15-5 | H-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| Acetyl-PACAP-38 (human, mouse, ovine, porcine, rat), Acetyl-Pituitary Adenylate Cyclase Activating Polypeptide-38 (human, mouse, ovine, porcine, rat) | C205H333N63O54S | 4576.36 | 156106-32-0 | Ac-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| PACAP-38 (6-38) (human, chicken, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-38 (6-38) (human, chicken, mouse, ovine, porcine, rat) | C182H300N56O45S | 4024.8 | 143748-18-9 | H-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| PACAP-38 (16-38) (human, chicken, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-38 (16-38) (human, chicken, mouse, ovine, porcine, rat) | C123H215N39O28S | 2720.37 | 144025-82-1 | H-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| PACAP-38 (28-38) (human, chicken, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-38 (28-38) (human, chicken, mouse, ovine, porcine, rat) | C61H110N24O14 | 1403.7 | 160489-86-1 | H-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| PACAP-38 (31-38) (human, chicken, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-38 (31-38) (human, chicken, mouse, ovine, porcine, rat) | C47H83N17O11 | 1062.28 | 138764-85-9 | H-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| Tyr-PDGF A-Chain (194-211) | C101H181N39O25 | 2341.8 | 137132-69-5 | H-Tyr-Gly-Arg-Pro-Arg-Glu-Ser-Gly-Lys-Lys-Arg-Lys-Arg-Lys-Arg-Leu-Lys-Pro-Thr-OH |
| PDGF Antagonist | C77H122N20O17 | 1599.94 | 143784-00-3 | H-Ala-Asn-Phe-Leu-Val-Trp-Glu-Ile-Val-Arg-Lys-Lys-Pro-OH |
| PDGF β-Receptor (719-723) (phosphorylated) | C30H48N5O10SP | 701.78 | H-Tyr(PO3H2)-Val-Pro-Met-Leu-OH | |
| PDGF β-Receptor (739-746) (phosphorylated) | C48H62N9O18SP | 1116.11 | H-Tyr(PO3H2)-Met-Ala-Pro-Tyr-Asp-Asn-Tyr-OH | |
| (Gln18)-Platelet Factor 4 (15-22) (human), (Gln18)-PF4 (15-22) (human), CT-112 | C38H69N15O13 | 944.06 | 144207-60-3 | H-Thr-Thr-Ser-Gln-Val-Arg-Pro-Arg-OH |
| Platelet Factor 4 (58-70) (human), PF4 (58-70) (human) | C76H133N17O18 | 1573.01 | 82989-21-7 | H-Pro-Leu-Tyr-Lys-Lys-Ile-Ile-Lys-Lys-Leu-Leu-Glu-Ser-OH |
| Pneumadin (human) | C41H70N12O14 | 955.08 | 130918-91-1 | H-Ala-Gly-Glu-Pro-Lys-Leu-Asp-Ala-Gly-Val-NH2 |
| Pneumadin (rat) | C47H74N12O15 | 1047.18 | 130918-90-0 | H-Tyr-Gly-Glu-Pro-Lys-Leu-Asp-Ala-Gly-Val-NH2 |
| (Tyr5·12,Lys7)-Polyphemusin II, T22 | C109H164N38O22S4 | 2487.01 | 147658-54-6 | H-Arg-Arg-Trp-Cys-Tyr-Arg-Lys-Cys-Tyr-Lys-Gly-Tyr-Cys-Tyr-Arg-Lys-Cys-Arg-NH2 (Disulfide bonds between Cys? and Cys¹?/Cys? and Cys¹³) |
| Polyphemusin II-Derived Peptide, T140 | C90H141N33O18S2 | 2037.45 | 229030-20-0 | H-Arg-Arg-2-Nal-Cys-Tyr-Arg-Lys-D-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-OH (Disulfide bond) |
本網(wǎng)頁(yè)所展示的有關(guān)【PAR-2 (1-6) (mouse, rat)_生化試劑_合肥賽曼諾生物科技有限公司】的信息/圖片/參數(shù)等由商一網(wǎng)的會(huì)員【合肥賽曼諾生物科技有限公司】提供，由商一網(wǎng)會(huì)員【合肥賽曼諾生物科技有限公司】自行對(duì)信息/圖片/參數(shù)等的真實(shí)性、準(zhǔn)確性和合法性負(fù)責(zé)，本平臺(tái)（本網(wǎng)站）僅提供展示服務(wù)，請(qǐng)謹(jǐn)慎交易，因交易而產(chǎn)生的法律關(guān)系及法律糾紛由您自行協(xié)商解決，本平臺(tái)（本網(wǎng)站）對(duì)此不承擔(dān)任何責(zé)任。您在本網(wǎng)頁(yè)可以瀏覽【PAR-2 (1-6) (mouse, rat)_生化試劑_合肥賽曼諾生物科技有限公司】有關(guān)的信息/圖片/價(jià)格等及提供【PAR-2 (1-6) (mouse, rat)_生化試劑_合肥賽曼諾生物科技有限公司】的商家公司簡(jiǎn)介、聯(lián)系方式等信息。
在您的合法權(quán)益受到侵害時(shí)，歡迎您向郵箱發(fā)送郵件，或者進(jìn)入《網(wǎng)站意見反饋》了解投訴處理流程，我們將竭誠(chéng)為您服務(wù)，感謝您對(duì)商一網(wǎng)的關(guān)注與支持！
